DoD DMRDP Military Infectious Diseases Clinical Trial Award — Defense Health Agency Contracting Activity - DHACA funding opportunity
Defense Health Agency Contracting Activity - DHACA · Federal agency

DoD DMRDP Military Infectious Diseases Clinical Trial Award

Overview: The FY14 DMRDP MID-CTA is intended to support early phase clinical trials/ testing with the potential to have a major impact on treatment of combat-related or trauma-induced wound infections. These studies must...

86
match
Award $0 Deadline 4629 days ago Location Alabama Type grant Level Federal Closed posted Jun 4, 2013
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: total funding pool ~$11,400,000.
  • Next deadline: October 17, 2013.
  • Issued by: Defense Health Agency Contracting Activity - DHACA.
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Award amount
$0
Deadline
4629 days ago
Oct 17, 2013
Total pool
$11.4M

About this opportunity

Overview: The FY14 DMRDP MID-CTA is intended to support early phase clinical trials/ testing with the potential to have a major impact on treatment of combat-related or trauma-induced wound infections. These studies must be responsive to the health care needs of military Service Members and Veterans; however, the use of military populations in the clinical trial/ testing is not a requirement. Proposed projects should be designed to demonstrate the safety and efficacy of novel therapies and diagnostics in human patients suffering from serious, debilitating combat-related or trauma-related wound infections. The purpose of such demonstrations is to accelerate translation of greater medical capabilities to patients; this can range from proof of concept ( first in human or Phase 0) trials through Phase II clinical trials, as well as Class III medical device trials/testing. Phase III trials for FDA licensure of drugs or definitive testing for device or assay clearance by the FDA will NOT be permitted under this Program Announcement/Funding Opportunity. Projects of interest are those focused on testing and translating investigational interventions or devices already proven in relevant definitive animal models and moving those interventions or devices into advanced clinical development.Funding from this award mechanism must support a clinical trial/testing and cannot be used for preclinical research studies. A clinical trial/testing is defined as a prospective accrual of human subjects where an intervention ( procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory , and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For this Program Announcement/Funding Opportunity the term “device” includes diagnostics ( in vivo, in vitro, and/or biomarkers). In vitro diagnostic products are those systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to prevent disease or its sequelae. Such products are intended for use in the examination of specimens taken from the human body. For this Program Announcement/Funding Opportunity the term “human subjects” refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information onclinical trials and phase/class of study, a Human Subject Resource Document is provided athttps://cdmrp.org/Program_Announcements_and_Forms/.If the proposed trial involves the use of a drug that has not been approved by the FDA for its investigational use, then an Investigational New Drug (IND) application may be required. If the proposed study involves an investigational device that has not been approved or cleared by the FDA for its investigational clinical use, the study may be required to comply with the FDA Investigational Device Exemption (IDE) regulations. If the documented status of the IND or IDE has not been obtained within 6 months of the award date, the award may be terminated for failure to comply with a material provision of the award.All of the following are important aspects of FY14 DMRDP MID-CTA application submission. The application should:• Include a clinical trial that begins no later than 12 months after the award date, if a clinical trial is proposed.• Include preliminary data relevant to the proposed research project.

Funding agency

Tags

Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID235939
PostedJun 4, 2013

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.